Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting tyrosine kinases involved in cancer cell proliferation. Shows potential in developing treatments for solid tumors due to its ability to selectively inhibit signaling pathways that drive tumor growth. Also employed in structure-activity relationship (SAR) studies to optimize drug candidates for improved potency and metabolic stability. Its morpholino and chloro substituents enhance solubility and binding affinity, making it valuable in designing orally bioavailable therapeutics.